View the BioMarin Pharmaceutical annual report 2023 below. Download this and previous annual reports by simply selecting the year. And read the PDF documents on your computer and mobile device.
Use Adobe Acrobat Reader® and Liquid Mode for best reading experience.
Download for your device
BioMarin's 2023 annual report showcases a year marked by significant milestones and strategic advancements. The company has continued to make remarkable progress in developing transformative therapies for rare genetic conditions. A number of pivotal clinical trials were completed, and new products were successfully launched, signaling strong growth potential for the upcoming years.
One of the major highlights of the year includes the approval and market launch of Roctavian for the treatment of hemophilia A. This milestone represents a significant step forward in BioMarin's mission to deliver innovative treatments that address unmet medical needs. Additionally, the expansion of the company's gene therapy platform has been a focal point, paving the way for future breakthroughs in genetic medicine.
Throughout 2023, BioMarin made strategic investments aimed at enhancing its research and development capabilities. Collaborations with various research institutions and biopharmaceutical companies have been forged to expedite the discovery and commercialization of new therapies. These partnerships are expected to drive long-term growth and bolster the company's position in the biopharmaceutical industry.
BioMarin experienced significant growth in revenue and profitability, attributed to the successful commercialization of newly approved products and the robust performance of its existing portfolio. The company managed to offset some of the losses from previous years, showing a positive trend in its financial health. Operational efficiencies and cost-management strategies were also improved, contributing to stronger financial outcomes.
NOTE: This summary was generated using OpenAI. We do not guarantee its accuracy.These annual reports were published by and are property of BioMarin Pharmaceutical.
Do you want to receive an email when a new BioMarin Pharmaceutical annual report is added to this page? Leave your email address here.
Yes. Leave your email address in the field above the table with annual reports. And press Submit. You'll be notified automatically when a new annual report of BioMarin Pharmaceutical is added to the page.
For enquiries regarding a physical (paper) copy of the annual report please refer to Investor Relations of BioMarin Pharmaceutical. Visit biomarin.com for more information
For questions regarding the content or publishing of an annual report please refer to Investor Relations of BioMarin Pharmaceutical. Visit biomarin.com for more information
If a link on AnnReports doesn't work, please let us know in an email to service@annpreports.com.
We have listed all BioMarin Pharmaceutical annual reports that we have found. If you're missing the latest annual report which you are certain has been published, please mail to service@annpreports.com. We'll add the report ASAP and mail you a link to the report.
If the company is not listed, we can not help you. But you can easily search the internet using the following search term: "COMPANY annual report YEAR filetype:pdf". The search results will only contain links to PDF files.'
You need to run the latest version of Adobe Acrobat Reader on your mobile device. And your smartphone or tablet needs to run on iOS 12 or Android 5.0 and later. Furthermore for now Liquid Mode can convert only up to 200 pages and a file size of less than 10 MB. Unfortunately some files are larger than this. Hopefully future versions of Adobe Acrobat Reader will be able to handle larger files.